查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2106360

2034年生物活性護膚成分市場預測－按成分類型、原料、功能、應用、最終用戶和地區分類的全球分析

Bioactive Skincare Ingredients Market Forecasts to 2034 - Global Analysis By Ingredient Type, Source, Function, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球生物活性護膚成分市場將達到 38 億美元，並在預測期內以 6.0% 的複合年成長率成長，到 2034 年達到 54 億美元。

生物活性護膚成分是指能夠與皮膚細胞相互作用，並在基礎保濕之外產生可衡量的生理效應的生物活性化合物。這些成分包括胜肽、透明質酸、神經醯胺、菸鹼醯胺、類視色素、抗氧化劑以及植物來源的生物活性物質，它們能夠穿透皮膚屏障，促進膠原蛋白生成、調節黑色素合成、加速細胞更新並提供光保護作用。它們透過受體介導路徑、酵素抑制和清除自由基等機制發揮作用，從而解決特定的皮膚問題，例如老化、色素沉著過度、發炎和皮膚屏障功能障礙。生物活性成分以適當的濃度添加到精華液、乳霜和護理產品中，既能發揮治療效果，又能最大限度地減少皮膚刺激。

高齡化社會的需求

隨著全球人口老化，消費者尋求以科學證據為基礎的抗衰老齡化護膚方案，導致對活性護膚成分的需求顯著成長。皮膚病學研究不斷證實胜肽和類視色素在促進膠原蛋白合成和減少細紋的有效性。高階化妝品品牌正採用更高濃度的活性成分來打造差異化的抗衰老產品線。消費者越來越願意投資經臨床驗證的護膚方案，這使得目標市場從傳統化妝品擴展到醫用級配方。這種人口結構的改變正在推動各類成分的持續銷售成長。

法規的複雜性

針對化妝品成分安全性和功效聲明的嚴格監管框架，為生物活性護膚成分生產商帶來了巨大的合規挑戰。根據歐盟化妝品法規和美國食品藥物管理局（FDA）的監管，必須進行廣泛的毒性測試並提供功效聲明的佐證。新生物活性化合物的註冊流程涉及漫長的評估期和高昂的文件成本。成分供應商必須遵守不同司法管轄區的不同標準，這使得全球產品上市更加複雜。這些監管障礙延長了產品上市時間，並增加了研發成本。

個人化護膚配方

基於基因譜分析和皮膚微生物組分析的個人化護膚興起，為生物活性成分供應商創造了變革性的機會。生物技術的進步使得客製化胜肽序列和針對個體皮膚狀況的標靶抗氧化劑混合物的開發成為可能。面向消費者的診斷平台的出現，推動了對客製化活性成分組合的需求。化妝品製造商正與生物技術公司合作，開發針對特定皮膚問題的定製配方。這種個人化趨勢不僅能夠達到高價位，還能培養長期的顧客忠誠度。

天然成分的替代

消費者對潔淨標示和天然來源替代品的偏好日益成長，對合成生物活性成分構成了競爭威脅。植物來源和發酵來源的活性成分正不斷擴大市場佔有率，因為消費者認為它們更安全、更永續。一些品牌正在改進產品配方，去除某些合成胜肽和類視色素，轉而採用植物來源的替代品。強調天然來源的行銷訊息能夠影響消費者的購買決策，而與實際功效無關。這種轉變正迫使傳統的生物活性成分供應商投資於採用綠色化學和生物技術的生產方法。

新型冠狀病毒（COVID-19）的影響：

新冠疫情初期擾亂了護膚中活性成分的供應鏈，導致原料短缺和生產延誤。然而，疫情也加速了人們對「肌膚健康」的關注，因為消費者在居家隔離期間有更多時間進行自我護理。居家護膚的興起帶動了對高效能活性成分的需求。疫情過後，關注皮膚屏障健康和考慮微生物群的配方已成為市場結構性趨勢。遠距辦公文化的建立也維持了人們對高階護膚的興趣，並推動了對活性成分創新領域的持續投資。

在預測期內，透明質酸細分市場預計將佔據最大的市場佔有率。

由於其適用於所有膚質，且經證實具有在細胞層面鎖住水分的功效，預計在預測期內，透明質酸細分市場將佔據最大的市場佔有率。玻尿酸是保濕霜、精華液和注射填充劑的主要成分，確保了大眾市場和高階化妝品製造商對其的穩定需求。它與其他生物活性成分的相容性使配方研發人員能夠開發出多功能產品，不僅能保濕，還能抗衰老和修復皮膚屏障功能。該成分已確立的安全性以及大量的臨床數據使其獲得了監管機構的廣泛批准。消費者對玻尿酸作為護膚主要成分的熟悉程度也鞏固了其市場主導地位。

在預測期內，生物技術衍生領域預計將呈現最高的複合年成長率。

在預測期內，生物技術衍生性商品領域預計將呈現最高的成長率，這主要得益於發酵技術和重組蛋白生產的快速發展。生物技術能夠創造出穩定性更高、生物活性更具標靶性的新型生物活性胜肽和生長因子。領先的化妝品製造商正擴大採購發酵衍生的成分，以實現其「清潔美容」和永續性目標。生物技術生產的擴充性有助於降低長期成本，同時確保批次間的一致性和純度。法律規範也不斷發展完善，以適應這些創新的生產方法，加速商業性化應用。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這主要得益於其成熟的化妝品行業基礎設施以及消費者對高階護膚品的高支出。美國憑藉其成熟的皮膚科護膚品行業以及眾多領先化妝品品牌對生物活性成分研發的大力投入，正在推動該地區的需求成長。先進的零售分銷網路和直銷電商通路促進了產品的快速開發。美國食品藥物管理局（FDA）的監管政策調整在保障安全標準的同時，也促進了創新。BASF SE）和亞什蘭公司（Ashland Inc.）等主要原料供應商在該地區擁有大規模的業務。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於中國、日本和韓國中產階級人口的快速成長以及消費者日益增強的美容意識。 「韓妝」和「日系護膚」的流行推高了消費者對高效活性成分的期望。國內製造商正大力投資生物技術研發，以開發自主的生物活性化合物。政府對化妝品和個人護理行業的扶持政策也為成分創新創造了有利環境。可支配收入的成長和社群媒體的影響力正在推動消費者對含有先進生物活性成分的高階護膚品的需求。

免費客製化服務：

所有購買此報告的客戶均可從以下免費自訂選項中選擇一項：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章：執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章：全球生物活性護膚成分市場：依成分類型分類

  • 胜肽
  • 玻尿酸
  • 神經醯胺
  • 菸鹼醯胺
  • 類視色素
  • 抗氧化劑
  • 植物來源的生物活性成分
  • 其他成分類型

第6章：全球生物活性護膚成分市場：依來源分類

  • 植物來源
  • 海洋來源
  • 微生物來源
  • 生物技術衍生
  • 合成
  • 其他來源

第7章：全球生物活性護膚成分市場：依功能分類

  • 抗衰老
  • 保濕
  • 美白
  • 消炎（藥）
  • 紫外線防護
  • 痤瘡治療
  • 皮膚修復

第8章：全球生物活性護膚成分市場：按應用領域分類

  • 臉部保養
  • 身體保養
  • 防曬油
  • 抗衰老產品
  • 祛痘產品
  • 眼部護理產品

第9章：全球生物活性護膚成分市場：依最終用戶分類

  • 化妝品製造商
  • 契約製造
  • 皮膚科診所
  • 個人護理品牌
  • 研究機構

第10章 全球生物活性護膚成分市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第11章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第12章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第13章：公司簡介

  • BASF SE
  • Croda International Plc
  • DSM-Firmenich AG
  • Evonik Industries AG
  • Ashland Inc.
  • Symrise AG
  • Clariant AG
  • Givaudan SA
  • Solvay SA
  • Lubrizol Corporation
  • Seppic SA
  • Lucas Meyer Cosmetics
  • CLR Berlin GmbH
  • Provital SA
  • Ichimaru Pharcos Co., Ltd.
  • Lonza Group AG
Product Code: SMRC38506

According to Stratistics MRC, the Global Bioactive Skincare Ingredients Market is accounted for $3.8 billion in 2026 and is expected to reach $5.4 billion by 2034 growing at a CAGR of 6.0% during the forecast period. Bioactive skincare ingredients refer to biologically active compounds that interact with skin cells to produce measurable physiological effects beyond basic moisturization. These ingredients include peptides, hyaluronic acid, ceramides, niacinamide, retinoids, antioxidants, and plant-derived bioactives that penetrate the skin barrier to stimulate collagen production, regulate melanin synthesis, enhance cellular turnover, and provide photoprotection. They function through receptor-mediated pathways, enzymatic inhibition, and free radical scavenging mechanisms to address specific dermatological concerns such as aging, hyperpigmentation, inflammation, and barrier dysfunction. Bioactive ingredients are formulated into serums, creams, and treatments at concentrations designed to achieve therapeutic thresholds while maintaining skin tolerance.

Market Dynamics:

Driver:

Aging population demand

The growing global aging population is driving substantial demand for bioactive skincare ingredients as consumers seek evidence-based solutions for age-related skin concerns. Dermatological research continues to validate the efficacy of peptides and retinoids in stimulating collagen synthesis and reducing fine lines. Premium cosmetic brands are incorporating higher concentrations of bioactives to differentiate their anti-aging product portfolios. Consumer willingness to invest in clinically proven skincare routines has expanded the addressable market beyond traditional cosmetics into medical-grade formulations. This demographic shift supports sustained revenue growth across ingredient categories.

Restraint:

Regulatory complexity

Stringent regulatory frameworks governing cosmetic ingredient safety and efficacy claims create significant compliance challenges for bioactive skincare ingredient manufacturers. The European Union's Cosmetics Regulation and the U.S. Food and Drug Administration's oversight require extensive toxicological testing and substantiation of performance claims. Registration processes for novel bioactive compounds involve lengthy evaluation periods and substantial documentation costs. Ingredient suppliers must navigate varying standards across jurisdictions, which complicates global product launches. These regulatory barriers increase time-to-market and elevate development expenses.

Opportunity:

Personalized skincare formulations

The emergence of personalized skincare based on genetic profiling and skin microbiome analysis presents transformative opportunities for bioactive ingredient suppliers. Biotechnology advances enable the development of customized peptide sequences and targeted antioxidant blends tailored to individual dermatological profiles. Direct-to-consumer diagnostic platforms are creating demand for bespoke active ingredient combinations. Cosmetic manufacturers are partnering with biotech firms to develop made-to-order formulations that address specific skin concerns. This personalization trend commands premium pricing and fosters long-term customer loyalty.

Threat:

Natural ingredient substitution

The accelerating consumer preference for clean-label and naturally derived alternatives poses a competitive threat to synthetic bioactive ingredients. Plant-based and fermentation-derived actives are gaining market share as consumers perceive them as safer and more sustainable. Some brands are reformulating products to eliminate certain synthetic peptides and retinoids in favor of botanical equivalents. Marketing narratives emphasizing natural origins can influence purchasing decisions regardless of comparative efficacy. This shift pressures traditional bioactive suppliers to invest in green chemistry and biotechnological production methods.

Covid-19 Impact:

The COVID-19 pandemic initially disrupted supply chains for bioactive skincare ingredients, causing raw material shortages and manufacturing delays. However, the crisis accelerated the skin health movement as consumers spent more time on self-care routines during lockdowns. The shift toward at-home skincare treatments increased demand for high-performance active ingredients. Post-pandemic, the emphasis on skin barrier health and microbiome-friendly formulations has become a structural market trend. Remote work culture sustained interest in premium skincare, supporting continued investment in bioactive ingredient innovation.

The hyaluronic acid segment is expected to be the largest during the forecast period

The hyaluronic acid segment is expected to account for the largest market share during the forecast period, due to its universal applicability across all skin types and its proven ability to retain moisture at the cellular level. Hyaluronic acid serves as a foundational ingredient in moisturizers, serums, and injectable fillers, which ensures consistent demand from both mass-market and premium cosmetic manufacturers. Its compatibility with other bioactives allows formulators to create multi-functional products that address hydration alongside anti-aging and barrier repair concerns. The ingredient's well-established safety profile and extensive clinical documentation support broad regulatory acceptance. Consumer familiarity with hyaluronic acid as a skincare staple reinforces its dominant commercial position.

The biotechnology-derived segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the biotechnology-derived segment is predicted to witness the highest growth rate, driven by rapid advances in fermentation technology and recombinant protein production. Biotechnology enables the creation of novel bioactive peptides and growth factors with enhanced stability and targeted biological activity. Major cosmetic manufacturers are increasingly sourcing fermentation-derived ingredients to meet clean beauty and sustainability commitments. The scalability of biotechnological production reduces long-term costs while ensuring batch consistency and purity. Regulatory frameworks are evolving to accommodate these innovative production methods, which accelerate commercial adoption across global markets.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to its mature cosmetic industry infrastructure and high consumer spending on premium skincare products. The United States leads regional demand with a well-established dermatological skincare segment and strong presence of major cosmetic brands investing in bioactive ingredient research. Advanced retail distribution networks and direct-to-consumer e-commerce channels facilitate rapid product commercialization. Regulatory clarity from the FDA supports innovation while maintaining safety standards. Leading ingredient suppliers such as BASF SE and Ashland Inc. maintain significant operational footprints in the region.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to rapidly expanding middle-class populations and increasing beauty consciousness across China, Japan, and South Korea. The Korean beauty and Japanese skincare movements have elevated consumer expectations for high-performance active ingredients. Domestic manufacturers are investing heavily in biotechnology research to develop proprietary bioactive compounds. Government initiatives supporting the cosmetics and personal care industry create favorable conditions for ingredient innovation. Rising disposable incomes and social media influence drive demand for premium skincare containing advanced bioactive formulations.

Key players in the market

Some of the key players in Bioactive Skincare Ingredients Market include BASF SE, Croda International Plc, DSM-Firmenich AG, Evonik Industries AG, Ashland Inc., Symrise AG, Clariant AG, Givaudan SA, Solvay S.A., Lubrizol Corporation, Seppic S.A., Lucas Meyer Cosmetics, CLR Berlin GmbH, Provital S.A., Ichimaru Pharcos Co., Ltd. and Lonza Group AG.

Key Developments:

In June 2026, BASF SE launched a next-generation peptide complex for anti-aging applications, achieving clinical validation for collagen synthesis enhancement across diverse skin types.

In May 2026, DSM-Firmenich AG expanded its biotechnology-derived ceramide production capacity in Europe to meet growing demand from premium skincare manufacturers.

In April 2026, Evonik Industries AG introduced a novel fermentation-based hyaluronic acid grade with enhanced molecular weight control for targeted skincare formulations.

Ingredient Types Covered:

  • Peptides
  • Hyaluronic Acid
  • Ceramides
  • Niacinamide
  • Retinoids
  • Antioxidants
  • Plant-Based Bioactives
  • Other Ingredient Types

Sources Covered:

  • Plant-Based
  • Marine-Based
  • Microbial-Based
  • Biotechnology-Derived
  • Synthetic
  • Other Sources

Functions Covered:

  • Anti-Aging
  • Moisturizing
  • Skin Brightening
  • Anti-Inflammatory
  • UV Protection
  • Acne Treatment
  • Skin Repair

Applications Covered:

  • Facial Care
  • Body Care
  • Sun Care
  • Anti-Aging Products
  • Acne Care Products
  • Eye Care Products

End Users Covered:

  • Cosmetic Manufacturers
  • Contract Manufacturers
  • Dermatology Clinics
  • Personal Care Brands
  • Research Institutions

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Bioactive Skincare Ingredients Market, By Ingredient Type

  • 5.1 Peptides
  • 5.2 Hyaluronic Acid
  • 5.3 Ceramides
  • 5.4 Niacinamide
  • 5.5 Retinoids
  • 5.6 Antioxidants
  • 5.7 Plant-Based Bioactives
  • 5.8 Other Ingredient Types

6 Global Bioactive Skincare Ingredients Market, By Source

  • 6.1 Plant-Based
  • 6.2 Marine-Based
  • 6.3 Microbial-Based
  • 6.4 Biotechnology-Derived
  • 6.5 Synthetic
  • 6.6 Other Sources

7 Global Bioactive Skincare Ingredients Market, By Function

  • 7.1 Anti-Aging
  • 7.2 Moisturizing
  • 7.3 Skin Brightening
  • 7.4 Anti-Inflammatory
  • 7.5 UV Protection
  • 7.6 Acne Treatment
  • 7.7 Skin Repair

8 Global Bioactive Skincare Ingredients Market, By Application

  • 8.1 Facial Care
  • 8.2 Body Care
  • 8.3 Sun Care
  • 8.4 Anti-Aging Products
  • 8.5 Acne Care Products
  • 8.6 Eye Care Products

9 Global Bioactive Skincare Ingredients Market, By End User

  • 9.1 Cosmetic Manufacturers
  • 9.2 Contract Manufacturers
  • 9.3 Dermatology Clinics
  • 9.4 Personal Care Brands
  • 9.5 Research Institutions

10 Global Bioactive Skincare Ingredients Market, By Geography

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
    • 10.1.3 Mexico
  • 10.2 Europe
    • 10.2.1 United Kingdom
    • 10.2.2 Germany
    • 10.2.3 France
    • 10.2.4 Italy
    • 10.2.5 Spain
    • 10.2.6 Netherlands
    • 10.2.7 Belgium
    • 10.2.8 Sweden
    • 10.2.9 Switzerland
    • 10.2.10 Poland
    • 10.2.11 Rest of Europe
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 South Korea
    • 10.3.5 Australia
    • 10.3.6 Indonesia
    • 10.3.7 Thailand
    • 10.3.8 Malaysia
    • 10.3.9 Singapore
    • 10.3.10 Vietnam
    • 10.3.11 Rest of Asia Pacific
  • 10.4 South America
    • 10.4.1 Brazil
    • 10.4.2 Argentina
    • 10.4.3 Colombia
    • 10.4.4 Chile
    • 10.4.5 Peru
    • 10.4.6 Rest of South America
  • 10.5 Rest of the World (RoW)
    • 10.5.1 Middle East
      • 10.5.1.1 Saudi Arabia
      • 10.5.1.2 United Arab Emirates
      • 10.5.1.3 Qatar
      • 10.5.1.4 Israel
      • 10.5.1.5 Rest of Middle East
    • 10.5.2 Africa
      • 10.5.2.1 South Africa
      • 10.5.2.2 Egypt
      • 10.5.2.3 Morocco
      • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

  • 11.1 Industry Value Network and Supply Chain Assessment
  • 11.2 White-Space and Opportunity Mapping
  • 11.3 Product Evolution and Market Life Cycle Analysis
  • 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

  • 12.1 Mergers and Acquisitions
  • 12.2 Partnerships, Alliances, and Joint Ventures
  • 12.3 New Product Launches and Certifications
  • 12.4 Capacity Expansion and Investments
  • 12.5 Other Strategic Initiatives

13 Company Profiles

  • 13.1 BASF SE
  • 13.2 Croda International Plc
  • 13.3 DSM-Firmenich AG
  • 13.4 Evonik Industries AG
  • 13.5 Ashland Inc.
  • 13.6 Symrise AG
  • 13.7 Clariant AG
  • 13.8 Givaudan SA
  • 13.9 Solvay S.A.
  • 13.10 Lubrizol Corporation
  • 13.11 Seppic S.A.
  • 13.12 Lucas Meyer Cosmetics
  • 13.13 CLR Berlin GmbH
  • 13.14 Provital S.A.
  • 13.15 Ichimaru Pharcos Co., Ltd.
  • 13.16 Lonza Group AG

List of Tables

  • Table 1 Global Bioactive Skincare Ingredients Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Bioactive Skincare Ingredients Market Outlook, By Ingredient Type (2023-2034) ($MN)
  • Table 3 Global Bioactive Skincare Ingredients Market Outlook, By Peptides (2023-2034) ($MN)
  • Table 4 Global Bioactive Skincare Ingredients Market Outlook, By Hyaluronic Acid (2023-2034) ($MN)
  • Table 5 Global Bioactive Skincare Ingredients Market Outlook, By Ceramides (2023-2034) ($MN)
  • Table 6 Global Bioactive Skincare Ingredients Market Outlook, By Niacinamide (2023-2034) ($MN)
  • Table 7 Global Bioactive Skincare Ingredients Market Outlook, By Retinoids (2023-2034) ($MN)
  • Table 8 Global Bioactive Skincare Ingredients Market Outlook, By Antioxidants (2023-2034) ($MN)
  • Table 9 Global Bioactive Skincare Ingredients Market Outlook, By Plant-Based Bioactives (2023-2034) ($MN)
  • Table 10 Global Bioactive Skincare Ingredients Market Outlook, By Other Ingredient Types (2023-2034) ($MN)
  • Table 11 Global Bioactive Skincare Ingredients Market Outlook, By Source (2023-2034) ($MN)
  • Table 12 Global Bioactive Skincare Ingredients Market Outlook, By Plant-Based (2023-2034) ($MN)
  • Table 13 Global Bioactive Skincare Ingredients Market Outlook, By Marine-Based (2023-2034) ($MN)
  • Table 14 Global Bioactive Skincare Ingredients Market Outlook, By Microbial-Based (2023-2034) ($MN)
  • Table 15 Global Bioactive Skincare Ingredients Market Outlook, By Biotechnology-Derived (2023-2034) ($MN)
  • Table 16 Global Bioactive Skincare Ingredients Market Outlook, By Synthetic (2023-2034) ($MN)
  • Table 17 Global Bioactive Skincare Ingredients Market Outlook, By Other Sources (2023-2034) ($MN)
  • Table 18 Global Bioactive Skincare Ingredients Market Outlook, By Function (2023-2034) ($MN)
  • Table 19 Global Bioactive Skincare Ingredients Market Outlook, By Anti-Aging (2023-2034) ($MN)
  • Table 20 Global Bioactive Skincare Ingredients Market Outlook, By Moisturizing (2023-2034) ($MN)
  • Table 21 Global Bioactive Skincare Ingredients Market Outlook, By Skin Brightening (2023-2034) ($MN)
  • Table 22 Global Bioactive Skincare Ingredients Market Outlook, By Anti-Inflammatory (2023-2034) ($MN)
  • Table 23 Global Bioactive Skincare Ingredients Market Outlook, By UV Protection (2023-2034) ($MN)
  • Table 24 Global Bioactive Skincare Ingredients Market Outlook, By Acne Treatment (2023-2034) ($MN)
  • Table 25 Global Bioactive Skincare Ingredients Market Outlook, By Skin Repair (2023-2034) ($MN)
  • Table 26 Global Bioactive Skincare Ingredients Market Outlook, By Application (2023-2034) ($MN)
  • Table 27 Global Bioactive Skincare Ingredients Market Outlook, By Facial Care (2023-2034) ($MN)
  • Table 28 Global Bioactive Skincare Ingredients Market Outlook, By Body Care (2023-2034) ($MN)
  • Table 29 Global Bioactive Skincare Ingredients Market Outlook, By Sun Care (2023-2034) ($MN)
  • Table 30 Global Bioactive Skincare Ingredients Market Outlook, By Anti-Aging Products (2023-2034) ($MN)
  • Table 31 Global Bioactive Skincare Ingredients Market Outlook, By Acne Care Products (2023-2034) ($MN)
  • Table 32 Global Bioactive Skincare Ingredients Market Outlook, By Eye Care Products (2023-2034) ($MN)
  • Table 33 Global Bioactive Skincare Ingredients Market Outlook, By End User (2023-2034) ($MN)
  • Table 34 Global Bioactive Skincare Ingredients Market Outlook, By Cosmetic Manufacturers (2023-2034) ($MN)
  • Table 35 Global Bioactive Skincare Ingredients Market Outlook, By Contract Manufacturers (2023-2034) ($MN)
  • Table 36 Global Bioactive Skincare Ingredients Market Outlook, By Dermatology Clinics (2023-2034) ($MN)
  • Table 37 Global Bioactive Skincare Ingredients Market Outlook, By Personal Care Brands (2023-2034) ($MN)
  • Table 38 Global Bioactive Skincare Ingredients Market Outlook, By Research Institutions (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.